Cargando…
Multi-omic tumor data reveal diversity of molecular mechanisms that correlate with survival
Outcomes for cancer patients vary greatly even within the same tumor type, and characterization of molecular subtypes of cancer holds important promise for improving prognosis and personalized treatment. This promise has motivated recent efforts to produce large amounts of multidimensional genomic (...
Autores principales: | Ramazzotti, Daniele, Lal, Avantika, Wang, Bo, Batzoglou, Serafim, Sidow, Arend |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203719/ https://www.ncbi.nlm.nih.gov/pubmed/30367051 http://dx.doi.org/10.1038/s41467-018-06921-8 |
Ejemplares similares
-
De novo mutational signature discovery in tumor genomes using SparseSignatures
por: Lal, Avantika, et al.
Publicado: (2021) -
Comprehensive genomic characterization of breast tumors with BRCA1 and BRCA2 mutations
por: Lal, Avantika, et al.
Publicado: (2019) -
SparseSignatures: An R package using LASSO-regularized non-negative matrix factorization to identify mutational signatures from human tumor samples
por: Mella, Lorenzo, et al.
Publicado: (2022) -
HAPDeNovo: a haplotype-based approach for filtering and phasing de novo mutations in linked read sequencing data
por: Zhou, Xin, et al.
Publicado: (2018) -
Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++
por: Davydov, Eugene V., et al.
Publicado: (2010)